Stephen J. Nicholls

发表

Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.

M. Chen, E. Tuzcu, P. Schoenhagen, 2006, Atherosclerosis.

Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2009, JACC. Cardiovascular interventions.

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Paul Schoenhagen, Milind Y Desai, Stanley L Hazen, 2007, JAMA.

Effect of ACAT inhibition on the progression of coronary atherosclerosis.

Carl J Pepine, Paul Schoenhagen, E. Michelson, 2006, The New England journal of medicine.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

J. Kastelein, J. Jukema, W. Koenig, 2014, JAMA.

C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy

P. Libby, M. Shao, R. Erbel, 2013, Circulation.

Effect of two intensive statin regimens on progression of coronary disease.

Peter Libby, P. Libby, R. Erbel, 2011, The New England journal of medicine.

Rate of progression of coronary atherosclerotic plaque in women.

E. Tuzcu, S. Hazen, P. Schoenhagen, 2007, Journal of the American College of Cardiology.

Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy

S. Hazen, H. Scoffone, H. Allayee, 2010, Journal of Lipid Research.

Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.

S. Hazen, S. Nissen, M. Brennan, 2011, Clinical chemistry.

Optimizing outcomes during left main percutaneous coronary intervention with intravascular ultrasound and fractional flow reserve: the current state of evidence.

E. Tuzcu, S. Kapadia, S. Nicholls, 2012, JACC. Cardiovascular interventions.

Exploring coronary atherosclerosis with intravascular imaging.

E. Tuzcu, R. Puri, S. Nissen, 2013, International journal of cardiology.

Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)

E. Tuzcu, J. Tardif, S. Nissen, 2008, Circulation.

Coronary Endothelium-Dependent Vasoreactivity and Atheroma Volume in Subjects With Stable, Minimal Angiographic Disease Versus Non–ST-Segment–Elevation Myocardial Infarction: An Intravascular Ultrasound Study

E. Tuzcu, S. Nissen, J. Beltrame, 2013, Circulation. Cardiovascular imaging.

Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruct

E. Tuzcu, Alfonso T. Perez, S. Nissen, 2011, Journal of the American College of Cardiology.

Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.

J. S. St. John, E. Tuzcu, S. Nissen, 2014, The American journal of cardiology.

Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.

P. Barter, S. Nicholls, B. Karlson, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial.

S. Nissen, Stephen J. Nicholls, Kausik K. Ray, 2023, The lancet. Diabetes & endocrinology.

Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus

M. Shao, E. Tuzcu, S. Nissen, 2013, European journal of preventive cardiology.

Application of intravascular ultrasound in anti-atherosclerotic drug development

Stephen J. Nicholls, Steven E. Nissen, E. Murat Tuzcu, 2006, Nature reviews. Drug discovery.

Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.

P. Libby, M. Shao, R. Erbel, 2017, Atherosclerosis.

Coronary artery calcification and changes in atheroma burden in response to established medical therapies.

Paul Schoenhagen, Stanley L Hazen, E. Tuzcu, 2007, Journal of the American College of Cardiology.

Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease

E. Tuzcu, S. Kapadia, S. Nissen, 2016, Circulation. Cardiovascular imaging.

Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial

F. Otsuka, H. Makino, T. Noguchi, 2024, Atherosclerosis plus.

The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events

M. Shao, E. Tuzcu, S. Kapadia, 2016, European journal of preventive cardiology.

Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2005, The American journal of cardiology.

Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade.

E. Tuzcu, S. Kapadia, S. Nissen, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics.

Deepak L. Bhatt, A. Lincoff, Darren K Mcguire, 2023, American heart journal.

Peripheral arterial disease and progression of coronary atherosclerosis.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2011, Journal of the American College of Cardiology.